This observation is in line with a recent study showing that extracellular matrix remodelling occurred during disease progression and that galectin-1, as part of the ECM proteins, had prognostic relevance for MM patient overall survival [3]. This evidence concerns the gene LGALS1 and Miyoshi myopathy.